Roush has built its reputation over the years with high-performance modifications to various Ford vehicles. The company has ...
Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...
Darius Dale, CEO & Founder, 42 Macro breaks down why the puck is moving away from the Mag 7 — and where capital is rotating ...